These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2575693)

  • 1. [Helicobacter pylori-induced cost-benefit risk considerations].
    Leiss O
    Leber Magen Darm; 1989 Dec; 19(6):333-5. PubMed ID: 2575693
    [No Abstract]   [Full Text] [Related]  

  • 2. [Campylobacter (Helicobacter) pylori-induced cost effectiveness-risk considerations].
    Rösch W
    Leber Magen Darm; 1990 Jan; 20(1):45-6. PubMed ID: 2107370
    [No Abstract]   [Full Text] [Related]  

  • 3. [What is safe in the treatment of Campylobacter pylori-induced gastritis and Campylobacter pylori-associated peptic ulcer?].
    Menge H
    Internist (Berl); 1988 Nov; 29(11):745-54. PubMed ID: 3069787
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cost-benefit analysis of conservative therapy of gastritis and peptic ulcer].
    Schütz E; Stolte M
    Leber Magen Darm; 1994 Jul; 24(4):147-9. PubMed ID: 7934607
    [No Abstract]   [Full Text] [Related]  

  • 5. [Eradication of Helicobacter pylori in peptic ulcer and chronic gastritis. A randomized clinical trial].
    Rodríguez Hernández H; Sánchez Anguiano LF; Quiñones E
    Rev Gastroenterol Mex; 1998; 63(1):21-7. PubMed ID: 10068745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of treatment regimens for the eradication of Helicobacter pylori in duodenal ulcer.
    Vakil N; Fennerty MB
    Am J Gastroenterol; 1996 Feb; 91(2):239-45. PubMed ID: 8607487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy of peptic ulcer and chronic gastritis with bismuth salts].
    Rösch W
    Z Gastroenterol; 1987 Sep; 25 Suppl 4():34-40. PubMed ID: 3687149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN; Hahm JS; Kim HJ
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Peptic ulcer and drug therapy].
    Tsuneoka K
    Nihon Naika Gakkai Zasshi; 1991 Jan; 80(1):1-2. PubMed ID: 1673699
    [No Abstract]   [Full Text] [Related]  

  • 10. Ranitidine bismuth citrate with clarithromycin given twice daily effectively eradicates Helicobacter pylori and heals duodenal ulcers.
    Bardhan KD; Wurzer H; Marcelino M; Jahnsen J; Lotay N; Roberts PM
    Am J Gastroenterol; 1998 Mar; 93(3):380-5. PubMed ID: 9517644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guidelines for the treatment of Helicobacter pylori in the pediatric population.
    Robinson DM; Abdel-Rahman SM; Nahata MC
    Ann Pharmacother; 1997 Oct; 31(10):1247-9. PubMed ID: 9337451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Elimination of Helicobacter pylori in patients with recurrent abdominal pain with simultaneous administration of ranitidine, bismuth subsalicylate and clarithromycin].
    Ramirez Mayans JA; Zamora Davila E; Cervantes Bustamante R; Mata Rivera N; Oyervides Garcia I; Cuevas S; Zarate Mondragón FE
    Acta Gastroenterol Latinoam; 1996; 26(5):281-3. PubMed ID: 9363265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effectiveness of short-term triple therapy for healing Helicobacter pylori infection in ulcer disease].
    Kobler E; Werth B; Wüst W; Reinhart WH
    Schweiz Med Wochenschr Suppl; 1997; 89():14S-16S. PubMed ID: 9289833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Quamatel application in three-drug eradication therapy of duodenal ulcer and gastroduodenal ulcerations associated with helicobacter pylori infection].
    Mansurova FKh; Kadyrov DM; Odinaev RI; Ishankulova DM
    Klin Med (Mosk); 2000; 78(6):53-6. PubMed ID: 10900873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of colloidal bismuth and its combination with amoxicillin on the elimination of Helicobacter pylori in patients with a duodenal ulcer and chronic antral gastritis].
    Piubello W; Aimo G; Soldinger E; Pistoso S; Raggi G; Superti G; Bonesi R; Vitali E
    Recenti Prog Med; 1993 Jan; 84(1):40-4. PubMed ID: 8430249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Modern policy of anti-helicobacter therapy of ulcer disease].
    Ryss ES
    Klin Med (Mosk); 1998; 76(10):7-11. PubMed ID: 9865008
    [No Abstract]   [Full Text] [Related]  

  • 17. Cost-effectiveness of Helicobacter pylori eradication therapy in duodenal ulcer disease.
    Jönsson B
    Scand J Gastroenterol Suppl; 1996; 215():90-5. PubMed ID: 8722390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antimicrobial drugs in the treatment of stomach and duodenal diseases associated with Campylobacter pylori].
    Perederiĭ VG; Rozhavin MA
    Klin Med (Mosk); 1989 Jan; 67(1):44-8. PubMed ID: 2654463
    [No Abstract]   [Full Text] [Related]  

  • 19. [Ulcer--campylobacter pylori--bismuth therapy].
    Internist (Berl); 1989 Feb; 30(2 Suppl [ULKUS]):1-11. PubMed ID: 2635701
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of gastritis-associated Helicobacter pylori infection in children].
    Velasco Benítez CA; Amorocho Pérez RD
    Rev Gastroenterol Peru; 2002; 22(2):159-63. PubMed ID: 12098744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.